产品设计开发高级科学家/资深科学家
2-4万
 南京-江宁区
 无需经验
 博士
 全职
 更新于03-04
收藏
先聊聊
职位信息

Responsibilities:
Develop and lead the autoimmune research group and work together within the China Research as well as across the business.
Lead preclinical programs for autoimmune diseases as well as develop targeted therapies utilizing the company's core platforms.
Defining the objectives, strategies, responsibilities, and tasks for the group members
Oversee the design and execution of in-vivo studies in numerous autoimmune disease models either on an internal basis or with external partners.
Lead the efforts to develop novel assays and/or animal models to validate therapeutic modalities.
Lead, mentor, and train team members; Provide effective leadership including individual performance goal setting, managing the development of entire team and all individuals, recognize and reward employee contributions, planning and facilitating team activities, responsible for hiring and selecting new personnel and motivating members of the functional area.
Identify possible therapeutic targets, contribute to portfolio strategy and work with multifunctional teams for execution of that strategy.
Interpret and analyze data as well as present findings to internal stakeholders and external collaborators.
Qualifications:
PhD in immunology or similar field with at least 3-5 years of post-doctoral experience and 5+ years in industry
Deep knowledge in T, B and DC biology and MoA of autoimmune diseases
Experience in human and mouse immunology as well as animal models of autoimmune diseases.
Previous experience with people management is required
Experience with directing programs from discovery to IND
Excellent organizational, written and oral communication skills, efficient time management and demonstrate high degree of flexibility
工作地址
 景佑路33号同方科技园
应届生安全提醒
求职过程中如果遇到违规收费、信息不实、以招聘名义的培训收费或者微信营销等虚假招聘行为,请保留证据,维护自己的合法权益。谨防上当受骗!
公司信息
传奇生物(NASDAQ: LEGN)是一家处于临床阶段的全球生物制药公司,专注于肿瘤和其他领域的新型细胞疗法的开发。目前,公司在中国、美国、欧洲拥有800多名员工。运用创新的技术手段、全球研发模式、生产策略和专业知识,公司具备强大的潜力为患者开发和制造一流的细胞疗法。传奇生物通过战略合作开发和商业化旗下主导产品西达基奥仑赛(cilta-cel),这是一种靶向BCMA的CAR-T细胞疗法用于治疗多发性***瘤患者,该药物目前正处于注册临床试验阶段。
下载App 查看公司其他职位
公司信息更多职位
img南京传奇生物科技有限公司
合资
1000-5000人
制药/生物工程
事业单位上岸交流帖!
希望自己能过面试。
求校招笔试题库!!!
同学,你找到了吗?
这个职位怎么样?
在我看来挺不错的一个职位
下载App 参与互动